Prostaglandin D2 and sleep/wake regulation

Sleep Medicine Reviews

Volumn 15, Issue 6, 2011, Pages 411-418

  Urade, Yoshihiro ^a   Hayaishi, Osamu ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Adenosine; Adenosine A1 receptor; Adenosine A2A receptor; DP1 receptor; Gene knockout mice; Histamine; Prostaglandin D2; Tuberomammillary nucleus; Ventrolateral preoptic area

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; CAFFEINE; HISTAMINE RECEPTOR; INTERLEUKIN 1BETA; ISOMERASE INHIBITOR; LIPOCALIN; ONO 4127NA; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; SELENIUM TETRACHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AROUSAL; CEREBROSPINAL FLUID; CHOROID PLEXUS; CIRCADIAN RHYTHM; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FOREBRAIN; GABAERGIC SYSTEM; HUMAN; HYPOTHALAMUS; INTRACELLULAR SIGNALING; KNOCKOUT MOUSE; MASTOCYTOSIS; MOLECULAR PATHOLOGY; NERVE CELL; NONREM SLEEP; OLIGODENDROGLIA; PREOPTIC AREA; REM SLEEP; REVIEW; SLEEP DEPRIVATION; SLEEP INDUCTION; SLEEP WAKING CYCLE; TUBEROMAMMILLARY NUCLEUS; ANIMAL; BRAIN; MOUSE; PHYSIOLOGY; SLEEP; SLEEP STAGE; WAKEFULNESS;

ADENOSINE; ANIMALS; BRAIN; HUMANS; MICE; PROSTAGLANDIN D2; SLEEP; SLEEP STAGES; WAKEFULNESS;

EID: 82155176834     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2011.08.003     Document Type: Review

References (71)

1. Ishimori K. True cause of sleep: a hypnogenic substance as evidenced in the brain of sleep-deprived animals. Tokyo Igakkai Zasshi 1909, 23:429-457.
2. Legendre R., Pieron H. Recherches sur le besoin de sommeil consécutif à une veille prolongée. Z Allegem Physiol 1913, 14:235-262.
3. Krueger J.M., Rector D.M., Roy S., Van Dongen H.P., Belenky G., Panksepp J. Sleep as a fundamental property of neuronal assemblies. Nat Rev Neurosci 2008, 9:910-919.
4. Huang Z.L., Urade Y., Hayaishi O. The role of adenosine in the regulation of sleep. Curr Top Med Chem 2011, 11:1047-1057.
5. McCarley R.W. Neurobiology of REM and NREM sleep. Sleep Med 2007, 8:302-330.
6. Porkka-Heiskanen T., Kalinchuk A.V. Adenosine, energy metabolism and sleep homeostasis. Sleep Med Rev 2011, 15:123-135.
7. Porkka-Heiskanen T., Strecker R.E., Thakkar M., Bjorkum A.A., Greene R.W., McCarley R.W. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997, 276:1265-1268.
8. Urade Y., Hayaishi O. Crucial role of prostaglandin D2 and adenosine in sleep regulation: experimental evidence from pharmacological approaches to gene-knockout mice. Future Neurol 2010, 5:363-376.
9. Garcia-Garcia F., Acosta-Pena E., Venebra-Munoz A., Murillo-Rodriguez E. Sleep-inducing factors. CNS Neurological Disorders Drug Targets 2009, 8:235-244.
10. Huitron-Resendiz S., Kristensen M.P., Sanchez-Alavez M., Clark S.D., Grupke S.L., Tyler C., et al. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 2005, 25:5465-5474.
11. Ueno R., Ishikawa Y., Nakayama T., Hayaishi O. Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. Biochem Biophys Res Commun 1982, 109:576-582.
12. Narumiya S., Ogorochi T., Nakao K., Hayaishi O. Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci 1982, 31:2093-2103.
13. Ogorochi T., Narumiya S., Mizuno N., Yamashita K., Miyazaki H., Hayaishi O. Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. J Neurochem 1984, 43:71-82.
14. Ueno R., Honda K., Inoue S., Hayaishi O. Prostaglandin D2, a cerebral sleep-inducing substance in rats. Proc Natl Acad Sci U S A 1983, 80:1735-1737.
15. Onoe H., Ueno R., Fujita I., Nishino H., Oomura Y., Hayaishi O. Prostaglandin D2, a cerebral sleep-inducing substance in monkeys. Proc Natl Acad Sci U S A 1988, 85:4082-4086.
16. Pandey H.P., Ram A., Matsumura H., Hayaishi O. Concentration of prostaglandin D2 in cerebrospinal fluid exhibits a circadian alteration in conscious rats. Biochem Mol Biol Int 1995, 37:431-437.
17. Ram A., Pandey H.P., Matsumura H., Kasahara-Orita K., Nakajima T., Takahata R., et al. CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats. Brain Res 1997, 751:81-89.
18. Roberts L.J., Sweetman B.J., Lewis R.A., Austen K.F., Oates J.A. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 1980, 303:1400-1404.
19. Pentreath V.W., Rees K., Owolabi O.A., Philip K.A., Doua F. The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Trans R Soc Trop Med Hyg 1990, 84:795-799.
20. Matsumura H., Nakajima T., Osaka T., Satoh S., Kawase K., Kubo E., et al. Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc Natl Acad Sci U S A 1994, 91:11998-12002.
21. Terao A., Matsumura H., Saito M. Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain. J Neurosci 1998, 18:6599-6607.
22. Urade Y., Fujimoto N., Hayaishi O. Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem 1985, 260:12410-12415.
23. Christ-Hazelhof E., Nugteren D.H. Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme. Biochim Biophys Acta 1979, 572:43-51.
24. Urade Y., Fujimoto N., Ujihara M., Hayaishi O. Biochemical and immunological characterization of rat spleen prostaglandin D synthetase. J Biol Chem 1987, 262:3820-3825.
25. Urade Y., Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm 2000, 58:89-120.
26. Urade Y., Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat 2002, 68-69:375-382.
27. Hirata M., Kakizuka A., Aizawa M., Ushikubi F., Narumiya S. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci U S A 1994, 91:11192-11196.
28. Hirai H., Tanaka K., Yoshie O., Ogawa K., Kenmotsu K., Takamori Y., et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001, 193:255-261.
29. Irikura D., Aritake K., Nagata N., Maruyama T., Shimamoto S., Urade Y. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase. J Biol Chem 2009, 284:7623-7630.
30. Aritake K., Kado Y., Inoue T., Miyano M., Urade Y. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem 2006, 281:15277-15286.
31. Eguchi N., Minami T., Shirafuji N., Kanaoka Y., Tanaka T., Nagata A., et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci U S A 1999, 96:726-730.
32. Taniike M., Mohri I., Eguchi N., Beuckmann C.T., Suzuki K., Urade Y. Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model. J Neurosci 2002, 22:4885-4896.
33. Ohinata K., Takagi K., Biyajima K., Fujiwara Y., Fukumoto S., Eguchi N., et al. Central prostaglandin D(2) stimulates food intake via the neuropeptide Y system in mice. FEBS Lett 2008, 582:679-684.
34. Mohri I., Taniike M., Taniguchi H., Kanekiyo T., Aritake K., Inui T., et al. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J Neurosci 2006, 26:4383-4393.
35. Taniguchi H., Mohri I., Okabe-Arahori H., Aritake K., Wada K., Kanekiyo T., et al. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. J Neurosci 2007, 27:4303-4312.
36. Urade Y., Kitahama K., Ohishi H., Kaneko T., Mizuno N., Hayaishi O. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci U S A 1993, 90:9070-9074.
37. Beuckmann C.T., Lazarus M., Gerashchenko D., Mizoguchi A., Nomura S., Mohri I., et al. Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat. J Comp Neurol 2000, 428:62-78.
38. Mizoguchi A., Eguchi N., Kimura K., Kiyohara Y., Qu W.M., Huang Z.L., et al. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci U S A 2001, 98:11674-11679.
39. Kumasaka T., Aritake K., Ago H., Irikura D., Tsurumura T., Yamamoto M., et al. Structural basis of the catalytic mechanism operating in open-closed conformers of lipocalin type prostaglandin D synthase. J Biol Chem 2009, 284:22344-22352.
40. Zhou Y., Shaw N., Li Y., Zhao Y., Zhang R., Liu Z.J. Structure-function analysis of human l-prostaglandin D synthase bound with fatty acid molecules. Faseb J 2010, 24:4668-4677.
41. Watanabe K., Urade Y., Mader M., Murphy C., Hayaishi O. Identification of beta-trace as prostaglandin D synthase. Biochem Biophys Res Commun 1994, 203:1110-1116.
42. Hoffmann A., Conradt H.S., Gross G., Nimtz M., Lottspeich F., Wurster U. Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J Neurochem 1993, 61:451-456.
43. Jordan W., Tumani H., Cohrs S., Eggert S., Rodenbeck A., Brunner E., et al. Prostaglandin D synthase (beta-trace) in healthy human sleep. Sleep 2004, 27:867-874.
44. Kohtoh S., Taguchi Y., Matsumoto N., Wada M., Huang Z., Urade Y. Algorithm for sleep scoring in experimental animals based on fast fourier transform power spectrum analysis of the electroencephalogram. Sleep Biol Rhythm 2008, 6:163-171.
45. Urade Y., Eguchi N., Qu W.M., Sakata M., Huang Z.L., Chen J.F., et al. Sleep regulation in adenosine A2A receptor-deficient mice. Neurology 2003, 61:S94-S96.
46. Scammell T.E., Gerashchenko D.Y., Mochizuki T., McCarthy M.T., Estabrooke I.V., Sears C.A., et al. An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 2001, 107:653-663.
47. Scammell T., Gerashchenko D., Urade Y., Onoe H., Saper C., Hayaishi O. Activation of ventrolateral preoptic neurons by the somnogen prostaglandin D2. Proc Natl Acad Sci U S A 1998, 95:7754-7759.
48. Satoh S., Matsumura H., Koike N., Tokunaga Y., Maeda T., Hayaishi O. Region-dependent difference in the sleep-promoting potency of an adenosine A2A receptor agonist. Eur J Neurosci 1999, 11:1587-1597.
49. Gallopin T., Luppi P.H., Cauli B., Urade Y., Rossier J., Hayaishi O., et al. The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A2A receptors in the ventrolateral preoptic nucleus. Neuroscience 2005, 134:1377-1390.
50. Hong Z.Y., Huang Z.L., Qu W.M., Eguchi N., Urade Y., Hayaishi O. An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J Neurochem 2005, 92:1542-1549.
51. Sherin J.E., Shiromani P.J., McCarley R.W., Saper C.B. Activation of ventrolateral preoptic neurons during sleep. Science 1996, 271:216-219.
52. Saper C.B., Scammell T.E., Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437:1257-1263.
53. Saper C.B., Fuller P.M., Pedersen N.P., Lu J., Scammell T.E. Sleep state switching. Neuron 2010, 68:1023-1042.
54. Huang Z.L., Sato Y., Mochizuki T., Okada T., Qu W.M., Yamatodani A., et al. Prostaglandin E2 activates the histaminergic system via the EP4 receptor to induce wakefulness in rats. J Neurosci 2003, 23:5975-5983.
55. Huang Z.L., Qu W.M., Li W.D., Mochizuki T., Eguchi N., Watanabe T., et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001, 98:9965-9970.
56. Hayaishi O., Urade Y., Eguchi N., Huang Z.L. Genes for prostaglandin D synthase and receptor as well as adenosine A2A receptor are involved in the homeostatic regulation of NREM sleep. Arch Ital Biol 2004, 142:533-539.
57. sleep of transgenic and gene-knockout mice for lipocalin-type prostaglandin D synthase. oxygen and life - oxygenases, oxidases and lipid mediator 2002, [Excerpta Medica]. N. Eguchi, E. Pinzar, Y. Kuwahata, T. Inui, T. Mochizuki, Y. Urade (Eds.).
58. Pinzar E., Kanaoka Y., Inui T., Eguchi N., Urade Y., Hayaishi O. Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc Natl Acad Sci U S A 2000, 97:4903-4907.
59. Qu W.M., Xu X.H., Yan M.M., Wang Y.Q., Urade Y., Huang Z.L. Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J Neurosci 2010, 30:4382-4389.
60. Huang Z.L., Mochizuki T., Qu W.M., Hong Z.Y., Watanabe T., Urade Y., et al. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A 2006, 103:4687-4692.
61. Qu W.M., Huang Z.L., Xu X.H., Aritake K., Eguchi N., Nambu F., et al. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proc Natl Acad Sci U S A 2006, 103:17949-17954.
62. Islam F., Watanabe Y., Morii H., Hayaishi O. Inhibition of rat brain prostaglandin D synthase by inorganic selenocompounds. Arch Biochem Biophys 1991, 289:161-166.
63. Huang Z.L., Qu W.M., Eguchi N., Chen J.F., Schwarzschild M.A., Fredholm B.B., et al. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 2005, 8:858-859.
64. Oishi Y., Huang Z.L., Fredholm B.B., Urade Y., Hayaishi O. Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc Natl Acad Sci U S A 2008, 105:19992-19997.
65. Jordan W., Tumani H., Cohrs S., Rodenbeck A., Ruther E., Bechthold J., et al. Narcolepsy increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy. J Neurol 2005, 252:1372-1378.
66. Bassetti C.L., Hersberger M., Baumann C.R. CSF prostaglandin D synthase is reduced in excessive daytime sleepiness. J Neurol 2006, 253:1030-1033.
67. Eguchi Y., Eguchi N., Oda H., Seiki K., Kijima Y., Matsu-ura Y., et al. Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci U S A 1997, 94:14689-14694.
68. Hirawa N., Uehara Y., Yamakado M., Toya Y., Gomi T., Ikeda T., et al. Lipocalin-type prostaglandin d synthase in essential hypertension. Hypertension 2002, 39:449-454.
69. Miwa Y., Oda H., Shiina Y., Shikata K., Tsushima M., Nakano S., et al. Association of serum lipocalin-type prostaglandin D synthase levels with subclinical atherosclerosis in untreated asymptomatic subjects. Hypertens Res 2008, 31:1931-1939.
70. Rétey J.V., Adam M., Honegger E., Khatami R., Luhmann U.F., Jung H.H., et al. A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc Natl Acad Sci U S A 2005, 102:15676-15681.
71. Lazarus M., Shen H.Y., Cherasse Y., Qu W.M., Huang Z.L., Bass C.E., et al. Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 2011, 31:10067-10075.